Cart
sales@molnova.com
MK-0873
CAS No. 500355-52-2
MK-0873( —— )
Catalog No. M34654 CAS No. 500355-52-2
MK-0873 is a novel and potent selective phosphodiesterase 4 (PDE4) inhibitor.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 200 | In Stock |
|
| 10MG | 302 | In Stock |
|
| 25MG | 489 | In Stock |
|
| 50MG | 695 | In Stock |
|
| 100MG | 977 | In Stock |
|
| 200MG | 1321 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameMK-0873
-
NoteResearch use only, not for human use.
-
Brief DescriptionMK-0873 is a novel and potent selective phosphodiesterase 4 (PDE4) inhibitor.
-
DescriptionMK-0873 is a novel and potent selective phosphodiesterase 4 (PDE4) inhibitor.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayAngiogenesis
-
TargetPDE
-
RecptorPDE
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number500355-52-2
-
Formula Weight422.44
-
Molecular FormulaC25H18N4O3
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESC(NC1CC1)(=O)C2=CN(C=3C(C2=O)=CC=CN3)C4=CC(C#CC5=CN(=O)=CC=C5)=CC=C4
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
CHF6001
A novel, highly potent and selective phosphodiesterase 4 (PDE4) inhibitor with IC50 of 0.026 nM.
-
Mopidamol
Mopidamol (RA 233) is a phosphodiesterase inhibitor, a dipyridamole derivative, with anticancer activity that prevents retinal vascular defects in experimental diabetes.
-
BAY 2666605
BAY 2666605 is an orally active inhibitor of PDE3A and PDE3B with IC50s of 87 nM and 50 nM, respectively. BAY 2666605 has anticancer effects.
